When Should Fractional-dose Vaccines be Used?

Problem definition: Vaccination campaigns often face significant operational challenges such as limited stockpiles, vaccine delivery delays, and constrained administration capacity. In such contexts, fractional-dose vaccines have been described in the medical literature as a possible strategy because their efficacy reduction is typically not commensurate with the level of fractionation, allowing greater population coverage. We seek to determine the optimal use and potential benefits of a fractionated vaccine dose with lower and more uncertain efficacy, given the specific supply constraints faced by a country. Methodology/results: We employ a susceptible-infected-recovered (SIR) epidemic model integrating vaccination with full and fractional doses over time. We embed it within a deterministic optimal control model aimed at identifying vaccination policies that minimize total infections during an epidemic, given operational constraints restricting the stockpile, delivery rate, and administration of vaccines. Using a statistical approach described in the clinical literature for estimating the uncertainty around fractional-dose efficacy, we conduct two application case studies grounded in real-world scenarios. Our theoretical analysis provides an intuitive characterization of the optimal vaccination policy that, depending on the epidemic and operational parameters, may utilize a combination of full- and fractional-dose vaccines, either simultaneously or sequentially. We also examine simpler policies that employ a single vaccine dosage throughout the epidemic. We conclude that, although these single-dose policies can often be almost as effective as the optimal policy in averting infections, they are not as robust to the uncertainty affecting fractional-dose vaccine efficacy. Managerial implications: Fractional-dose vaccines, used either alone or in conjunction with full-dose vaccines, present an opportunity to significantly reduce infections during an epidemic in resource-constrained settings. The proportion of fractional-dose vaccines relative to full-dose vaccines in a campaign should generally increase with the maximum vaccine administration rate and decrease with the total antigen stockpile available.

Authors

Publication Details

Journal
London Business School Research Online (London Business School)
Published
2026-03-30
Primary Topic
COVID-19 epidemiological studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When Should Fractional-dose Vaccines be Used?

F De Véricourt, J Gallien, N Ghosh
London Business School Research Online (London Business School)
COVID-19 epidemiological studies
article

When Should Fractional-dose Vaccines be Used?

F De Véricourt, J Gallien, N Ghosh
article en

Abstract

Problem definition: Vaccination campaigns often face significant operational challenges such as limited stockpiles, vaccine delivery delays, and constrained administration capacity. In such contexts, fractional-dose vaccines have been described in the medical literature as a possible strategy because their efficacy reduction is typically not commensurate with the level of fractionation, allowing greater population coverage. We seek to determine the optimal use and potential benefits of a fractionated vaccine dose with lower and more uncertain efficacy, given the specific supply constraints faced by a country. Methodology/results: We employ a susceptible-infected-recovered (SIR) epidemic model integrating vaccination with full and fractional doses over time. We embed it within a deterministic optimal control model aimed at identifying vaccination policies that minimize total infections during an epidemic, given operational constraints restricting the stockpile, delivery rate, and administration of vaccines. Using a statistical approach described in the clinical literature for estimating the uncertainty around fractional-dose efficacy, we conduct two application case studies grounded in real-world scenarios. Our theoretical analysis provides an intuitive characterization of the optimal vaccination policy that, depending on the epidemic and operational parameters, may utilize a combination of full- and fractional-dose vaccines, either simultaneously or sequentially. We also examine simpler policies that employ a single vaccine dosage throughout the epidemic. We conclude that, although these single-dose policies can often be almost as effective as the optimal policy in averting infections, they are not as robust to the uncertainty affecting fractional-dose vaccine efficacy. Managerial implications: Fractional-dose vaccines, used either alone or in conjunction with full-dose vaccines, present an opportunity to significantly reduce infections during an epidemic in resource-constrained settings. The proportion of fractional-dose vaccines relative to full-dose vaccines in a campaign should generally increase with the maximum vaccine administration rate and decrease with the total antigen stockpile available.

London Business School Research Online (London Business School)
Good health and well-being
Openalex Percentile: Top 99%
COVID-19 epidemiological studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

When Should Fractional-dose Vaccines be Used? — F De Véricourt, J Gallien, et al. · London Business School Research Online (London Business School) (2026) | TGRS Research Map | TGRS